Literature DB >> 28643246

Current Overview of TALEN Construction Systems.

Tetsushi Sakuma1, Takashi Yamamoto2.   

Abstract

Transcription activator-like effector (TALE) nuclease (TALEN) is the second-generation genome editing tool consisting of TALE protein containing customizable DNA-binding repeats and nuclease domain of FokI enzyme. Each DNA-binding repeat recognizes one base of double-strand DNA, and functional TALEN can be created by a simple modular assembly of these repeats. To easily and efficiently assemble the highly repetitive DNA-binding repeat arrays, various construction systems such as Golden Gate assembly, serial ligation, and ligation-independent cloning have been reported. In this chapter, we summarize the current situation of these systems and publically available reagents and protocols, enabling optimal selection of best suited systems for every researcher who wants to utilize TALENs in various research fields.

Keywords:  Golden Gate assembly; Ligation-independent cloning; Pre-assembled library; Serial ligation; TALEN

Mesh:

Substances:

Year:  2017        PMID: 28643246     DOI: 10.1007/978-1-4939-7128-2_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.

Authors:  Naoki Yahata; Yuji Matsumoto; Minoru Omi; Naoki Yamamoto; Ryuji Hata
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

2.  IFITM3 affects the level of antibody response after influenza vaccination.

Authors:  Na Lei; Yan Li; Qiang Sun; Jian Lu; Jianfang Zhou; Zi Li; Liqi Liu; Junfeng Guo; Kun Qin; Haibin Wang; Jianhong Zhao; Chong Li; Lingli Sun; Dayan Wang; Zhendong Zhao; Yuelong Shu
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

Review 3.  Acceleration of cancer science with genome editing and related technologies.

Authors:  Tetsushi Sakuma; Takashi Yamamoto
Journal:  Cancer Sci       Date:  2018-10-31       Impact factor: 6.716

4.  T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human.

Authors:  Qian Sun; Xiying Zhang; Limei Wang; Xujie Gao; Yanjuan Xiong; Liang Liu; Feng Wei; Lili Yang; Xiubao Ren
Journal:  Cell Death Dis       Date:  2019-06-17       Impact factor: 8.469

Review 5.  Applications and Major Achievements of Genome Editing in Vegetable Crops: A Review.

Authors:  Young-Cheon Kim; Yeeun Kang; Eun-Young Yang; Myeong-Cheoul Cho; Roland Schafleitner; Jeong Hwan Lee; Seonghoe Jang
Journal:  Front Plant Sci       Date:  2021-06-11       Impact factor: 5.753

6.  Characterization of knockin mice at the Rosa26, Tac1 and Plekhg1 loci generated by homologous recombination in oocytes.

Authors:  Youmei Wu; María José Luna; Lauren S Bonilla; Nicholas J P Ryba; James M Pickel
Journal:  PLoS One       Date:  2018-02-27       Impact factor: 3.240

Review 7.  Engineering altered protein-DNA recognition specificity.

Authors:  Adam J Bogdanove; Andrew Bohm; Jeffrey C Miller; Richard D Morgan; Barry L Stoddard
Journal:  Nucleic Acids Res       Date:  2018-06-01       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.